Study identifier: NCT03523585 Synced from ClinicalTrials.gov · August 05, 2026
● Completed

DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02]

Condition: Breast Cancer  ·  Sponsor: Daiichi Sankyo

PhasePhase 3
Planned participants608
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study will compare DS 8201a to standard treatment. Participants must have HER2 breast cancer that has been treated before. Their cancer: * cannot be removed by an operation * has spread to other parts of the body

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (227)

Ironwood Cancer Research CentersChandler, Arizona, United States
UCLA Hematology Oncology - Main SiteLos Angeles, California, United States
Pacific Cancer CareMonterey, California, United States
Sharp Memorial HospitalSan Diego, California, United States
Innovative Clinical Research InstituteWhittier, California, United States
Smilow Cancer Hospital at Yale New HavenNew Haven, Connecticut, United States
Washington Cancer InstituteWashington D.C., District of Columbia, United States
Florida Cancer Specialists-BroadwayFort Myers, Florida, United States
Piedmont Cancer Institute, PCAtlanta, Georgia, United States
Kapiolani Medical Center for Women and Children/Univ of HIHonolulu, Hawaii, United States
Loyola University Health SystemMaywood, Illinois, United States
Community HospitalMunster, Indiana, United States

+ 215 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →